by Frank Bergman, Slay News:
A team of bioweapon scientists has announced that they have successfully developed a mutant strain of “bird flu” that kills 100% of all humans who become infected with the virus.
The new strain was developed by South Korean gain-of-function researchers, who boast that the killer virus is 100% lethal for all mammals.
In addition, the virus was modified to allow it to enter human cells more effectively, making it far more contagious.
TRUTH LIVES on at https://sgtreport.tv/
The alarming death rate was confirmed in lab tests when the scientists achieved total elimination in infected mice.
The scientists manipulated the virus to adapt inside their bodies and spread to others.
The team was led by Drs. Deok-Hwan Kim and Dong-Yeop Lee of Konkuk University in Seoul.
The results of their experiments were published in the Virology Journal.
It raises serious concerns about dangerous gain-of-function (GOF) research still being pursued worldwide, with American tax dollars once again funding “next-generation” pandemic vaccine platforms in parallel.
The chilling study confirms what many warned about during the Covid era: scientists are still playing God with viruses that could spark the next global pandemic.
This time, researchers at Korea’s Konkuk University used a highly pathogenic strain of H5N1 avian influenza, which already had a tiny 4% presence of a mammal-adapting mutation (PB2-E627K).
Within days, that mutation exploded in the infected mice’s lungs and brains, killing every single host and spreading efficiently to other mice.
“All challenged mice died by 8 days… all contact mice died within 12 days,” the researchers boasted in their paper.
This wasn’t some accident or nature taking its course, however.
This was a deliberate experiment designed to see what would happen when a known mammal-adaptive mutation was unleashed in a controlled environment.
The outcome was exactly what many feared: the virus not only killed every subject but also evolved to do it better and faster.
And while these researchers were crafting mouse-killing viral strains in South Korea, the U.S. Department of Health and Human Services (HHS) quietly launched a $500 million program to develop “universal” bird flu vaccines.
The move eerily mirrors the vaccine-first mindset that dominated the Covid response.
